World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 4 May 2020
Main ID:  ChiCTR2000032622
Date of registration: 2020-05-04
Prospective Registration: No
Primary sponsor: Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Public title: Research for right cardiac function evaluation and warning model of neonatal pulmonary arterial hypertension
Scientific title: Research for right cardiac function evaluation and warning model of neonatal pulmonary arterial hypertension
Date of first enrolment: 2020-05-01
Target sample size: Target condition:100;Difficult condition:0
Recruitment status: Pending
URL:  http://www.chictr.org.cn/showproj.aspx?proj=53172
Study type:  Diagnostic test
Study design:  Sequential  
Phase:  0
Countries of recruitment
China
Contacts
Name: Maojun Li   
Address:  32 West Second Section First Ring Road, Chengdu, Sichuan, China
Telephone: +86 18981838016
Email: hanman2012@163.com
Affiliation:  Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Name: Binzhi Tang   
Address:  32 West Second Section First Ring Road, Chengdu, Sichuan, China
Telephone: +86 15928052638
Email: tomabishi@163.com
Affiliation:  Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Key inclusion & exclusion criteria
Inclusion criteria: In October 2018 to May 2020 in our hospital intensive care unit (NICU) appear in hospital centricity blue (premature PaO2 < 6.67 kPa, full term PaO2 < 8 kPa) neonatal cardiopulmonary disease.
Exclusion criteria: Congenital heart disease (not including arterial catheter not closed) and affect the well known, myocardial motion of neuromuscular diseases

Age minimum:
Age maximum:
Gender: Male
Health Condition(s) or Problem(s) studied
pulmonary arterial hypertension
Intervention(s)
Gold Standard:Clinical outcome;Index test:echocardiographic;
Primary Outcome(s)
Death Rate;SEN, SPE, ACC, AUC of ROC;heart function assessment;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Medical association of Sichuan Province
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 29/04/2020
Contact:
Zhou Liu
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history